GP73 expression was generally weak in HBV-C (Figure 1B), moderately positive in CHB (Figure 1C), strongly positive in severe hepatitis (Figure 1D), compensated LC (Figure 1E), and HCC (Figure 1F). This evidence concerns the gene GOLM1 and hepatocellular carcinoma.